欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1113/002
药品名称
Sevikar 40 mg/5 mg
活性成分
amlodipine 5.0 mg
olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Daiichi Sankyo Europe GmbH München Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Romania (RO)
SEVIKAR 40 mg/5 mg comprimate filmate
Germany (DE)
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Sevikar
Italy (IT)
Greece (GR)
许可日期
2008/07/30
最近更新日期
2024/03/05
药物ATC编码
C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
Clean common_pl_sev_clean_updAMLoverdose_IAIN_202206_VRE
Date of last change:2022/11/18
Final SPC
|
common_spc_sev_clean_updAMLoverdose_IAIN_202206_VRE
Date of last change:2022/08/09
Final Labelling
|
common label Sevikar combined
Date of last change:2016/03/21
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase